Clinical Trial Update: Vector Delivery of the IL-12 Gene in Men With Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a vector-delivered interleukin-12 (IL-12) gene in men with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• IL-12 gene delivery vector (interleukin-12 gene delivery vector)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Prostatic Neoplasms, Prostate Cancer | Phase 1 | Status: COMPLETED